Burkina Faso vs Central African Republic: Treatment success rate for patients treated for MDR-TB
Burkina Faso
69.0%
in 2022
Central African Republic
69.0%
in 2021
Burkina Faso rank
101st
Central African Republic rank
101st
Treatment success rate for patients treated for MDR-TB over time
- Burkina Faso
- Central African Republic
How they compare
Burkina Faso currently reports 69.0% against 69.0% in Central African Republic, a difference of 0.0%.
The two have swapped places 4 times across 10 shared years of data; in 2012 it was Central African Republic ahead.
Burkina Faso ranks 101st and Central African Republic ranks 101st of 163 countries.
Central African Republic has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Burkina Faso | Central African Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 64.6% | 75.0% | 10.4% | Central African Republic |
| 2020s | 67.5% | 74.5% | 7.0% | Central African Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Burkina Faso or Central African Republic?
- Burkina Faso, at 69.0% against 69.0% in Central African Republic as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Burkina Faso and Central African Republic?
- 0.0%, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Central African Republic?
- 10 years are reported by both, from 2012 to 2021.
- How do Burkina Faso and Central African Republic rank globally for treatment success rate for patients treated for mdr-tb?
- Burkina Faso ranks 101st and Central African Republic ranks 101st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.